Syngene International

Syngene International Interest Coverage

The Interest Coverage Ratio of Syngene International (SYNGENE.NS) as of Oct 31, 2026 is 134.53. In the previous year, Interest Coverage Ratio was 34.08 — a change of 294.72% (higher).

Interest Coverage

134.53

YoY

294.72%

Last updated:

Interest Coverage Ratio of Syngene International is 2025 134.53 . Interest Coverage Ratio of Syngene International was 2024 34.08 . It decreases by 294.72% higher compared to the previous year.

The Syngene International Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
4.90 INR
Jan 1, 2019
18.81 INR
Jan 1, 2020
13.62 INR
Jan 1, 2021
16.94 INR
Jan 1, 2022
12.11 INR
Jan 1, 2023
27.90 INR
Jan 1, 2024
34.08 INR
Jan 1, 2025
134.53 INR
The Syngene International Interest Coverage history
YEARInterest CoverageYoY
134.53+294.72%
34.08+22.18%
27.90+130.32%
12.11-28.49%
16.94+24.35%
13.62-27.58%
18.81+283.86%
4.90-24.76%
6.51-74.03%
25.07-8.23%
27.32+181.02%
9.72—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Syngene International Stock analysis

What does Syngene International do? Syngene International Ltd. was founded in Bangalore, India in 1993 and specializes in the development and manufacturing of pharmaceuticals, as well as biotechnology services. It is a global contract research organization and part of the Biocon Group, a leading biotech company based in India. Syngene's business model is based on collaborations with global customers in the pharmaceutical, biotech, and agrochemical industries. The company offers a wide range of services including research and development, preclinical development, active pharmaceutical ingredients manufacturing, formulation development, clinical development, and commercial manufacturing. Syngene operates in various divisions, including research and development, formulation development, preclinical services, clinical development, and manufacturing of active pharmaceutical ingredients and formulations. It has multiple locations, including research centers in Hyderabad, Chennai, and Pune, in addition to its headquarters in Bangalore. The company is known for its innovative and socially responsible practices, and has received several awards and recognitions, including the Golden Peacock Award for Corporate Social Responsibility in 2018 and the Best Indian CRO Award at the Global Pharma Excellence Awards in 2019. Syngene aims to establish itself as a global leader in biotech and pharmaceutical discovery and development services, with a focus on customer satisfaction and employee experience. It has become a trusted partner for clients in the pharmaceutical, biotech, and agrochemical industries, offering a wide range of services to support drug and biotech product development. Overall, Syngene International Ltd. is a key player in the contract research and development market, providing comprehensive services to support the development and manufacturing of pharmaceutical and biotechnology products. Syngene International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syngene International stock

Interest Coverage Ratio of Syngene International is 134.53 in 2025.

Interest Coverage Ratio of Syngene International changed from 34.08 to 134.53, representing a 294.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Syngene International since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Syngene International with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Syngene International

All Key Metrics — Syngene International